The Politics Of Generic Drugs
The way E. Thomas Arington sees it, his company is David taking on Goliath. For nearly a decade, the CEO of Cincinnati-based Duramed Pharmaceuticals Inc. has sought Food & Drug Administration approval for a generic version of America's most widely prescribed drug, a brew of estrogens called Premarin. Standing in the way is American Home Products Corp. and its subsidiary Wyeth-Ayerst Laboratories Inc., which makes Premarin from the urine of pregnant mares.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Smartphones Are Killing Americans, But Nobody’s Counting
- Why a Pub in the Middle of Nowhere Was Named the World’s Best Restaurant
- Gulf Coast Oil Spill May Be Largest Since 2010 BP Disaster
- Marc Faber Asked to Leave Sprott Board After Racist Report
- Airbus Snaps Up Bombardier Jet in New Challenge to Boeing